Published in J Clin Endocrinol Metab on December 01, 2000
Thyroid status, cardiovascular risk, and mortality in older adults. JAMA (2006) 3.50
The spectrum of thyroid disease and risk of new onset atrial fibrillation: a large population cohort study. BMJ (2012) 2.65
Subclinical hyperthyroidism and the risk of coronary heart disease and mortality. Arch Intern Med (2012) 2.24
Cardiovascular involvement in patients with different causes of hyperthyroidism. Nat Rev Endocrinol (2010) 1.28
Lipid abnormalities and cardiometabolic risk in patients with overt and subclinical thyroid disease. J Lipids (2011) 0.97
Impact of diagnosis of diabetes on health-related quality of life among high risk individuals: the Diabetes Prevention Program outcomes study. Qual Life Res (2013) 0.96
Thyroid hormones and cardiovascular disease. Nat Rev Cardiol (2016) 0.93
The role of thyroid hormone in the pathophysiology of heart failure: clinical evidence. Heart Fail Rev (2008) 0.93
Subclinical hyperthyroidism: to treat or not to treat? Postgrad Med J (2004) 0.90
Thyroid function and left ventricular structure and function in the Framingham Heart Study. Thyroid (2010) 0.85
Cardiovascular complications secondary to Graves' disease: a prospective study from Ukraine. PLoS One (2015) 0.85
The 2015 European Thyroid Association Guidelines on Diagnosis and Treatment of Endogenous Subclinical Hyperthyroidism. Eur Thyroid J (2015) 0.84
Quality of life (QoL) in patients with benign thyroid goiters (pre- and post-thyroidectomy): a prospective study. World J Surg (2013) 0.83
Thyroid and aging or the aging thyroid? An evidence-based analysis of the literature. J Thyroid Res (2013) 0.82
Thyroid hormone and cardiac disease: from basic concepts to clinical application. J Thyroid Res (2011) 0.82
Health status, mood, and cognition in experimentally induced subclinical thyrotoxicosis. J Clin Endocrinol Metab (2008) 0.82
Five-year longitudinal evaluation of quality of life in a cohort of patients with differentiated thyroid carcinoma. J Zhejiang Univ Sci B (2011) 0.82
Altered thyroid status affects myocardial expression of connexin-43 and susceptibility of rat heart to malignant arrhythmias that can be partially normalized by red palm oil intake. Histochem Cell Biol (2016) 0.81
Thyroid hormone status and health-related quality of life in the LifeLines Cohort Study. Thyroid (2013) 0.81
Myocardial ultrastructure in cardiac hypertrophy induced by thyroid hormone--an acute study in rats. Virchows Arch (2005) 0.79
The thyroid hormone, parathyroid hormone and vitamin D associated hypertension. Indian J Endocrinol Metab (2011) 0.79
Thyroid Hormone-Regulated Cardiac microRNAs are Predicted to Suppress Pathological Hypertrophic Signaling. Front Endocrinol (Lausanne) (2014) 0.79
P wave duration and dispersion in patients with hyperthyroidism and the short-term effects of antithyroid treatment. Indian Pacing Electrophysiol J (2009) 0.78
The effects of levothyroxine replacement or suppressive therapy on health status, mood, and cognition. J Clin Endocrinol Metab (2014) 0.78
Improvement of quality of life in patients with benign goiter after surgical treatment. Langenbecks Arch Surg (2014) 0.76
Differences in Mouse Hepatic Thyroid Hormone Transporter Expression with Age and Hyperthyroidism. Eur Thyroid J (2015) 0.76
Fatty acid metabolism and thyroid hormones. Curr Trends Endocinol (2012) 0.76
Electrocardiographic and scintigraphic evaluation of patients with subclinical hyperthyroidism during workout. Endocrine (2016) 0.75
Management of subclinical hyperthyroidism. Int J Endocrinol Metab (2012) 0.75
Genome-Wide Analysis Identifies IL-18 and FUCA2 as Novel Genes Associated with Diastolic Function in African Americans with Sickle Cell Disease. PLoS One (2016) 0.75
A case report of suicidal behavior related to subclinical hyperthyroidism. Neuropsychiatr Dis Treat (2014) 0.75
Lean body mass-based levothyroxine replacement in young athyrotic patients with differentiated carcinoma of thyroid. Indian J Endocrinol Metab (2013) 0.75
Quantitative Assessment of Cardiac Function in Fetuses of Women with Maternal Gestational Thyroid Dysfunction Using VVI Echocardiography. Med Sci Monit (2015) 0.75
[Improvement of symptoms in mild hyperthyroidism with an extract of Lycopus europaeus (Thyreogutt® mono)]. Wien Med Wochenschr (2012) 0.75
Prolongation of the QT interval and the sudden infant death syndrome. N Engl J Med (1998) 8.49
Guidelines for diagnosis and therapy of MEN type 1 and type 2. J Clin Endocrinol Metab (2001) 6.12
Current perspectives on statins. Circulation (2000) 3.83
Human CD4(+)CD25(+) cells: a naturally occurring population of regulatory T cells. Blood (2001) 3.66
The role of T helper 17 (Th17) and regulatory T cells (Treg) in human organ transplantation and autoimmune disease. Clin Exp Immunol (2007) 3.51
A preliminary study of growth hormone in the treatment of dilated cardiomyopathy. N Engl J Med (1996) 3.44
Prevention of atherosclerosis in apolipoprotein E-deficient mice by bone marrow transplantation. Science (1995) 3.10
Disruption of the 12/15-lipoxygenase gene diminishes atherosclerosis in apo E-deficient mice. J Clin Invest (1999) 2.54
Massive xanthomatosis and altered composition of atherosclerotic lesions in hyperlipidemic mice lacking acyl CoA:cholesterol acyltransferase 1. J Clin Invest (2000) 2.21
Increased prevalence of thyroid autoimmunity in patients successfully treated for Cushing's disease. Clin Endocrinol (Oxf) (2000) 2.19
Prolactinomas resistant to standard dopamine agonists respond to chronic cabergoline treatment. J Clin Endocrinol Metab (1997) 2.14
Two mutations of BRCA2 gene at exon and splicing site in a woman who underwent oncogenetic counseling. Ann Oncol (2009) 2.13
Reduced atherosclerotic lesions in mice deficient for total or macrophage-specific expression of scavenger receptor-A. Arterioscler Thromb Vasc Biol (2000) 2.12
Impairment of GH secretion in adults with primary empty sella. J Endocrinol Invest (2002) 2.09
Sympathetic deactivation by growth hormone treatment in patients with dilated cardiomyopathy. Eur Heart J (1998) 2.05
Methodology-dependent variation in documentation of outcome predictors in out-of-hospital cardiac arrest. Acad Emerg Med (1995) 2.01
Subclinical Cushing's syndrome in patients with adrenal incidentaloma: clinical and biochemical features. J Clin Endocrinol Metab (2000) 1.99
Elevated one-hour post-load plasma glucose levels identifies subjects with normal glucose tolerance but early carotid atherosclerosis. Atherosclerosis (2009) 1.94
BRAF mutations in papillary thyroid carcinomas inhibit genes involved in iodine metabolism. J Clin Endocrinol Metab (2007) 1.93
Dynamics of a nosocomial outbreak of multidrug-resistant Pseudomonas aeruginosa producing the PER-1 extended-spectrum beta-lactamase. J Clin Microbiol (2001) 1.92
Imatinib inhibits the activation and proliferation of normal T lymphocytes in vitro. Leukemia (2004) 1.84
Effectiveness of bystander cardiopulmonary resuscitation and survival following out-of-hospital cardiac arrest. JAMA (1995) 1.83
Continuous relation between left ventricular mass and cardiovascular risk in essential hypertension. Hypertension (2000) 1.81
Cardiac effects of long term thyrotropin-suppressive therapy with levothyroxine. J Clin Endocrinol Metab (1993) 1.80
Macrophage lipoprotein lipase promotes foam cell formation and atherosclerosis in vivo. J Clin Invest (1999) 1.76
Relation between serum uric acid and carotid intima-media thickness in healthy postmenopausal women. Intern Emerg Med (2007) 1.72
Vascular smooth muscle cell dysfunction in patients with migraine. Neurology (2009) 1.71
Generation of atypical pulmonary inflammatory responses in BALB/c mice after immunization with the native attachment (G) glycoprotein of respiratory syncytial virus. J Virol (1996) 1.69
Control of adrenergic overactivity by beta-blockade improves the quality of life in patients receiving long term suppressive therapy with levothyroxine. J Clin Endocrinol Metab (1994) 1.69
Macrophage lipoprotein lipase promotes foam cell formation and atherosclerosis in low density lipoprotein receptor-deficient mice. J Biol Chem (2000) 1.68
Expression of the Na+/I- symporter gene in human thyroid tumors: a comparison study with other thyroid-specific genes. J Clin Endocrinol Metab (1999) 1.67
Prevalence of thyroid diseases in patients with acromegaly: results of an Italian multi-center study. J Endocrinol Invest (2002) 1.65
Persistence of increased cardiovascular risk in patients with Cushing's disease after five years of successful cure. J Clin Endocrinol Metab (1999) 1.62
High prevalence of reflux symptoms in duodenal ulcer patients who develop gastro-oesophageal reflux disease after curing Helicobacter pylori infection. Dig Liver Dis (2001) 1.61
Search for supersymmetry using final states with one lepton, jets, and missing transverse momentum with the ATLAS detector in √s=7 TeV pp collisions. Phys Rev Lett (2011) 1.60
One year of liraglutide treatment offers sustained and more effective glycaemic control and weight reduction compared with sitagliptin, both in combination with metformin, in patients with type 2 diabetes: a randomised, parallel-group, open-label trial. Int J Clin Pract (2011) 1.59
Prostatic hyperplasia: an unknown feature of acromegaly. J Clin Endocrinol Metab (1998) 1.58
Iodine-induced thyrotoxicosis in Kivu, Zaire. Lancet (1996) 1.57
Percutaneous computed tomography-guided ethanol injection in aldosterone-producing adrenocortical adenoma. Eur J Endocrinol (1995) 1.56
The molecular basis of alloreactivity. Immunol Today (1990) 1.56
Consensus statement: medical management of acromegaly. Eur J Endocrinol (2005) 1.54
Growth hormone and the heart. Endocr Rev (1994) 1.53
Accuracy of a new monoclonal stool antigen test in post-eradication assessment of Helicobacter pylori infection: comparison with the polyclonal stool antigen test and urea breath test. Dig Liver Dis (2005) 1.52
Increased cholesterol efflux in apolipoprotein AI (ApoAI)-producing macrophages as a mechanism for reduced atherosclerosis in ApoAI((-/-)) mice. Arterioscler Thromb Vasc Biol (2001) 1.52
Improved cardiovascular risk factors and cardiac performance after 12 months of growth hormone (GH) replacement in young adult patients with GH deficiency. J Clin Endocrinol Metab (2001) 1.51
Guidelines for acromegaly management. J Clin Endocrinol Metab (2002) 1.48
From endothelial dysfunction to atherosclerosis. Autoimmun Rev (2010) 1.47
Nitric oxide modulation of neutrophil-endothelium interaction: difference between arterial and venous coronary bypass grafts. J Am Coll Cardiol (1998) 1.47
Thyrotropin receptor mutations and thyroid hyperfunctioning adenomas ten years after their first discovery: unresolved questions. Thyroid (2003) 1.46
Predictive value of pentagastrin test for preoperative differential diagnosis between C-cell hyperplasia and medullary thyroid carcinoma in patients with moderately elevated basal calcitonin levels. Clin Endocrinol (Oxf) (2009) 1.46
Synergistic interactions of physiologic increments of glucagon, epinephrine, and cortisol in the dog: a model for stress-induced hyperglycemia. J Clin Invest (1979) 1.46
Dental caries and enamel defects in very low birth weight adolescents. Caries Res (2010) 1.44
Detection of an activating mutation of the thyrotropin receptor in a case of an autonomously hyperfunctioning thyroid insular carcinoma. J Clin Endocrinol Metab (1997) 1.44
Bone loss determined by quantitative ultrasonometry correlates inversely with disease activity in patients with endogenous glucocorticoid excess due to adrenal mass. Eur J Endocrinol (2001) 1.44
Human lymphocyte-activating properties of a purified polysaccharide from Candida albicans: B and T cell cooperation in the mitogenic response. J Immunol (1980) 1.44
Identification and antimicrobial susceptibility testing of clinical isolates of nonfermenting gram-negative bacteria by the Phoenix Automated Microbiology System. New Microbiol (2002) 1.43
Peptide analogues as a strategy to induce tolerance in T cells with indirect allospecificity. Transplantation (2000) 1.43
Finasteride in the treatment of hirsutism: new therapeutic perspectives. Fertil Steril (1996) 1.43
Speculations on the specificity of suppression. Immunol Today (1989) 1.43
Growth hormone and heart performance. A novel mechanism of cardiac wall stress regulation in humans. Eur Heart J (1997) 1.43
Antigen presentation by keratinocytes induces tolerance in human T cells. Eur J Immunol (1990) 1.43
Adenovirus-mediated transfer of the thyroid sodium/iodide symporter gene into tumors for a targeted radiotherapy. Cancer Res (2000) 1.43
Observation of a centrality-dependent dijet asymmetry in lead-lead collisions at sqrt[S(NN)] =2.76 TeV with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.41
NOD2/CARD15 in healthy relatives of IBD patients. Eur Rev Med Pharmacol Sci (2006) 1.41
Hypertensive left ventricular remodeling and ACE-gene polymorphism. Cardiovasc Res (1999) 1.41
The effect of quinagolide and cabergoline, two selective dopamine receptor type 2 agonists, in the treatment of prolactinomas. Clin Endocrinol (Oxf) (2000) 1.40
Different dysregulations in adrenal steroid biosynthesis as a prevalent cause of hyperandrogenism in women from southern Italy. Fertil Steril (1997) 1.40
Obesity and cardiac function. Circulation (1981) 1.39
[Effectiveness of and tolerability to oral desmopressin in the treatment of central diabetes insipidus]. Minerva Med (1992) 1.39
Measurement of dijet azimuthal decorrelations in pp collisions at sqrt(s)=7 TeV. Phys Rev Lett (2011) 1.39
Cardiac arrest witnessed by prehospital personnel: intersystem variation in initial rhythm as a basis for a proposed extension of the Utstein recommendations. Ann Emerg Med (1997) 1.39
Chronic treatment with CV 205-502 restores the gonadal function in hyperprolactinemic males. Eur J Endocrinol (1996) 1.39
The orbital veins. Am J Ophthalmol (1967) 1.39
Chemotherapy-based control of schistosomiasis haematobia. I. Metrifonate versus praziquantel in control of intensity and prevalence of infection. Am J Trop Med Hyg (1988) 1.38
Translational mini-review series on Th17 cells: induction of interleukin-17 production by regulatory T cells. Clin Exp Immunol (2009) 1.37
Left ventricular diastolic dysfunction in patients with subclinical hypothyroidism. J Clin Endocrinol Metab (1999) 1.36
Endoscopic endonasal transsphenoidal approach: outcome analysis of 100 consecutive procedures. Minim Invasive Neurosurg (2002) 1.35
Determination of the strange-quark density of the proton from ATLAS measurements of the W→ℓν and Z→ℓℓ cross sections. Phys Rev Lett (2012) 1.34
Impact of hyperthyroidism and its correction on vascular reactivity in humans. Circulation (2001) 1.34
Genetic analysis in Italian families with inflammatory bowel disease supports linkage to the IBD1 locus--a GISC study. Eur J Hum Genet (1999) 1.32
Search for new particles in two-jet final states in 7 TeV proton-proton collisions with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.32
Anergic T cells inhibit the antigen-presenting function of dendritic cells. J Immunol (2000) 1.32
Peroxisome proliferator-activated receptor-gamma agonist troglitazone protects against nondiabetic glomerulosclerosis in rats. Kidney Int (2001) 1.32
Generation of suppressor cells in the response of human lymphocytes to a polysaccharide from Candida albicans. J Immunol (1981) 1.31
Increased aggressiveness of thyroid cancer in patients with Graves' disease. J Clin Endocrinol Metab (1990) 1.31
Secretion-capture role for apolipoprotein E in remnant lipoprotein metabolism involving cell surface heparan sulfate proteoglycans. J Biol Chem (1994) 1.29
Controlled trial of botulinum toxin injection versus placebo and pneumatic dilation in achalasia. Gastroenterology (1996) 1.28
Enhanced binding and uptake of remnant lipoproteins by hepatic lipase-secreting hepatoma cells in culture. J Biol Chem (1994) 1.27
Hepatic apo E expression is required for remnant lipoprotein clearance in the absence of the low density lipoprotein receptor. J Clin Invest (1998) 1.25